Trial Profile
A Trial of Evaluating Additional Benefit of Cilostazol to Dual Antiplatelet Therapy in Patients With Long or Multi-vessel Coronary Artery Disease Underwent Biolimus-Eluting Stent Implantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Coronary artery restenosis; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms ABCD
- 01 Feb 2014 Results published in the American Heart Journal.
- 11 Mar 2013 Primary endpoint 'Cardiovascular-event-rate' has not been met.
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.